Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

AGH

  • Home
  •  
  • AGH



  • Most Read
  • Latest Comments
  • Althea Group delivering record year following expansion into global markets
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Althea Group delivering record year following expansion into global markets
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • Althea Group delivering record year following expansion into global markets
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • Althea Group delivering record year following expansion into global markets
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • Althea Group delivering record year following expansion into global markets
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • ECS Botanics secures distribution rights to bring Terphogz’s ‘The Original Z’ cannabis strain to Australia
    ECS Botanics secures distribution rights to bring Terphogz’s ‘The Original Z’ cannabis strain to Australia
    • News

  • Bioxyne leads the way as Australia’s first manufacturer of pharmaceutical cannabis gummies
    Bioxyne leads the way as Australia’s first manufacturer of pharmaceutical cannabis gummies
    • News

  • Melodiol moves to clear debt with $12m asset fire sale
    Melodiol moves to clear debt with $12m asset fire sale
    • News

  • Althea to make a splash in the US with new cannabis-based sodas
    Althea to make a splash in the US with new cannabis-based sodas
    • News

  • Melodiol Global Health reports revenue growth amid wider acceptance of medicinal cannabis products
    Melodiol Global Health reports revenue growth amid wider acceptance of medicinal cannabis products
    • News

  • Althea Group delivering record year following expansion into global markets
    • News

    Althea Group delivering record year following expansion into global markets

    The cheers of the cannabis industry can be heard loud and clear as the demand for the plant continues to prop up their profits. The last few years have been huge for the industry as companies attempt to strengthen earnings by out-scaling competitors.  One company hoping to come out on top is Althea Group (ASX:

    Read More
    Public
  • Free weed for the leprechauns as Althea Group enters Ireland
    • News

    Free weed for the leprechauns as Althea Group enters Ireland

    The burgeoning arms of cannabis treatment have made their way to Ireland, with regulators easing restrictions which has increased the amount of qualified retailers.  Currently, there is a limited number of cannabis retailers in the Republic of Ireland. Today, Althea Group Holdings (ASX: AGH) has been granted a rare opportunity to enter the Irish cannabis

    Read More
    Public
  • Yep, cannabis-infused beer is a thing and Althea is brewing it in Canada
    • News

    Yep, cannabis-infused beer is a thing and Althea is brewing it in Canada

    The ever progressive Canadians just know how to have fun which is just one reason cannabis-infused beverages are proving a major hit in the Great White North. Seeking to capitalising on this trend is medicines and recreational cannabis company Althea (ASX: AGH) which has partnered with beer giant The Boston Beer Company (NYSE: SAM) to

    Read More
    Public
  • Althea to launch low-cost cannabis as medicinal gateway option
    • News

    Althea to launch low-cost cannabis as medicinal gateway option

    If Australians have reservations about the use of medicinal cannabis to cure their ailments, there will soon be a low-cost option to trial cannabis products, with Althea Group (ASX: AGH) to launch a new range of low dosage oils to give first-time users an affordable entry point. The new ‘flexi’ cannabis oil products, as the

    Read More
    Public
  • Althea lands first purchase order with WeedMD for cannabis products
    • News

    Althea lands first purchase order with WeedMD for cannabis products

    Medicinal cannabis and research company Althea Group (ASX: AGH) has today announced that its Canadian subsidiary, Peak Processing, has received a binding purchase order from WeedMD Rx (A subsidiary of canadian listed company WeedMD Inc, TSX-V: WMD).  The CAD$130,000 order will see Peak perform a variety of services for WeedMD, including hydrocarbon extraction of fresh-frozen

    Read More
    Public
  • A new world beckons for the listed medical cannabis stocks, but liberalisation is not what it seems
    • Opinion

    A new world beckons for the listed medical cannabis stocks, but liberalisation is not what it seems

    Having been subject to a harsh reality check over the last year or so, the ASX listed cannabis sector is applauding the local medicine regulator’s endorsement of the weed as an effective therapy that should be more freely available to the ailing masses. But the path to the pharmacy is likely to be harder than

    Read More
    Public
  • 1
  • 2

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.